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Abstract
The Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3 degrade host hemoglobin to provide free amino
acids for parasite protein synthesis. Hemoglobin hydrolysis has been described as an ordered process initiated by aspartic
proteases, but cysteine protease inhibitors completely block the process, suggesting that cysteine proteases can also
initiate hemoglobin hydrolysis. To characterize the specific roles of falcipains, we used three approaches. First, using random
P1 –P 4 amino acid substrate libraries, falcipain-2 and falcipain-3 demonstrated strong preference for cleavage sites with Leu
at the P2 position. Second, with overlapping peptides spanning a and b globin and proteolysis-dependent
18O labeling,
hydrolysis was seen at many cleavage sites. Third, with intact hemoglobin, numerous cleavage products were identified. Our
results suggest that hemoglobin hydrolysis by malaria parasites is not a highly ordered process, but rather proceeds with
rapid cleavage by falcipains at multiple sites. However, falcipain-2 and falcipain-3 show strong specificity for P2 Leu in small
peptide substrates, in agreement with the specificity in optimized small molecule inhibitors that was identified previously.
These results are consistent with a principal role of falcipain-2 and falcipain-3 in the hydrolysis of hemoglobin by P.
falciparum and with the possibility of developing small molecule inhibitors with optimized specificity as antimalarial agents.
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Introduction
Malaria, especially that caused by Plasmodium falciparum,i s
responsible for hundreds of millions of episodes of disease, and
probably at least one million deaths each year [1,2]. Among
impediments to effective control of this disease is increasing
resistance to most available drugs [3]. New artemisinin-based
combination therapies offer excellent efficacy, but resistance to
most artemisinin partner drugs has already been seen [4], and
resistance to artemisinins may be emerging [5]. The pipeline for
development of other classes of effective antimalarials, especially
compounds that act against novel biochemical targets, is limited.
To facilitate development of such compounds, it is important to
characterize the biochemical features and biological roles of new
drug targets.
Falcipain-2 and falcipain-3 are papain-family cysteine proteases
of P. falciparum that are currently the subjects of in-depth drug
discovery efforts [6]. These proteases are expressed sequentially
across the life cycle of erythrocytic parasites, with expression of
falcipain-2 beginning in early trophozoites followed by expression
of falcipain-3 in late trophozoites and schizonts [7]. The proteases
are hemoglobinases that reside in the food vacuole of intraeryth-
rocytic parasites, where they degrade hemoglobin, in concert with
other proteases [8], to provide the parasite with amino acids for
growth and development [9]. Treatment of erythrocytic parasites
with cysteine protease inhibitors or disruption of the falcipain-2
gene results in accumulation of undegraded hemoglobin in the
food vacuole, confirming a role for this enzyme in hemoglobin
hydrolysis [6,10]. Disruption of the falcipain-3 gene could not be
achieved, but the gene was readily replaced with a tagged
functional copy, indicating that falcipain-3 is essential for survival
of intraerythrocytic parasites [11]. These results support studies of
falcipain inhibitors as new antimalarial agents.
The hydrolysis of hemoglobin by malaria parasites is a massive
proteolytic enterprise, which appears to be responsible for the
degradation of most erythrocytic hemoglobin over the course of a
48 hour developmental cycle [8,12]. It has been described as an
ordered pathway, with initial cleavage by aspartic proteases
followed by action of other proteases, eventually leading to free
amino acids [12]. However, falcipain inhibitors completely block
hemoglobin hydrolysis by erythrocytic parasites [13], and
falcipain-2 and falcipain-3 hydrolyze native hemoglobin under
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that falcipains also initiate hemoglobin hydrolysis in P. falciparum.
To better characterize the roles of falcipain-2 and falcipain-3, we
evaluated activities of these proteases against a library of small
peptide substrates, a series of larger peptides spanning the
sequences of a and b globin, and intact human hemoglobin.
Falcipain-2 and falcipain-3 demonstrated a marked preference for
cleavage of small peptide substrates with P2 Leu, but the enzymes
showed less specificity against larger peptides and intact
hemoglobin, with hydrolysis at multiple sites. These results suggest
that hemoglobin hydrolysis by P. falciparum is not a highly ordered
process, but rather that falcipain-2 and falcipain-3 rapidly cleave
hemoglobin at multiple sites to facilitate rapid hydrolysis of this
substrate.
Methods
Synthesis of Recombinant Falcipains
Expression, solubilization and refolding of falcipain-2 and
falcipain-3 were performed as described elsewhere, with slight
modifications [15,16,17]. In brief, urea solubilized inclusion bodies
from bacteria over-expressing the mature domains of either
falcipain-2 or falcipain-3 fused to a 66HIS tag were purified by
ultra-filtration and bound to Nickel-Nitrilotriacetic acid (Ni-NTA)
columns. After several washes with buffer containing 8 M urea
and 10–60 mM imidazole, bound protein was eluted sequentially
with 500 mM and 1 M imidazole in the presence of urea.
Refolding of falcipain-2 was achieved by diluting the eluates 100-
fold in 100 mM Tris-HCl, 30% glycerol, 250 mM arginine, 1 mM
EDTA, 1 mM reduced-glutathione (GSH), 1 mM oxidized-
glutathione (GSSG), pH 9.2 and incubating at 4uC overnight.
Refolding of falcipain-3 was achieved by diluting the eluates 100-
fold in 100 mM Tris-HCl, 15% sucrose, 250 mM arginine, 1 mM
EDTA, 1 mM GSH, 1 mM GSSG, pH 9.2 and incubating at 4uC
overnight. The refolded proteins were concentrated 50-fold, run
over a Q-Sepharose column, and eluted with a gradient of NaCl
starting at 500 mM. Eluates were examined by SDS-PAGE and
for activity against the synthetic substrate, Z-Leu-Arg-AMC
(benzyloxycarbonyl-Leu-Arg-7-amino-4-methyl-coumarin). Frac-
tions with highest enzyme activity were pooled and concentrated
using a 10 KDa cut-off ultra-filtration column (Amicon). Enzymes
were stored in 50% glycerol at 280uC.
P1-P 4 Specificity Determination Using Tetrapeptide
Scanning Libraries
To determine the P1-P 4 specificity of falcipain-2 and falcipain-
3, complete diverse positional scanning substrate libraries were
used [18]. The libraries were composed of peptide-conjugated
ACC (7-amino-4-carbamoylmethylcoumarin) fluorophore sub-
strates and contained 160,000 different P1-P 4 peptide sequences.
In the P1-, P2-, P3-, and P4- libraries, the P1-4 positions were
spatially addressed with 20 amino acids (cysteine was replaced with
norleucine); whereas the remaining three positions were random-
ized with equimolar mixtures of 20 amino acids (cysteine was
replaced with norleucine). The cleavage of the substrates by a
protease released free ACC, resulting in a shift of the excitation
and emission maxima from 325 and 400 nm to 380 and 460 nm,
respectively.
Falcipain-2 (50 nM) and falcipain-3 (300 nM) were assayed in
triplicate at 25uC in 100 mM sodium acetate, 100 mM NaCl,
1 mM DTT, 1 mM EDTA, 0.01% Brij-35, 1% v/v DMSO,
pH 5.5. Aliquots of 25 nmol (in 1 ml) from each of 20 sub-libraries
of the P1-, P2-, P3-, and P4- libraries were added to the wells of a
96-well Microfluor-1 U-bottom plate (Dynex Technologies). The
final concentration of each compound was 31.25 nM in 100 ml
final reaction volume. The assays were initiated by addition of pre-
activated enzyme and monitored fluorometrically for 30 min with
a SpectraMax Gemini fluorescence spectrometer (Molecular
Devices) with excitation at 380 nm, emission at 460 nm, and
cutoff at 435 nm.
Hydrolysis of globin peptides in the presence of H2
18O
Synthetic peptides of 12 amino acid length scanning the entire
sequences of a and b globin, with 4 amino acid overlaps between
peptides, were custom-ordered from Sigma-Genosys. Each peptide
(250 mM) was incubated in duplicate with 65 nM falcipain-2 or
falcipain-3 in 25 mM sodium acetate, pH 5.5, 2 mM DTT, and
50% H2
18Oa t3 7 uC. Reactions were started by adding enzyme
after spotting the 0 minute time point. Aliquots were spotted after
0, 5, 10, 15, 20, 40, 60, 75, 90, 120, and 180 minutes, and
overnight directly onto stainless steel MALDI-target plates
(Applied Biosystems) and mixed with an equal volume of matrix
(10 mg/ml sinapinic acid in 50% acetonitrile, 0.1% trifluoroacetic
acid) which stopped the proteolytic reactions. MALDI-TOF MS/
MS analysis was performed on a 4800 Proteomics Analyzer mass
spectrometer (Applied Biosystems) in positive ion mode equipped
with TOF/TOF optics and a 200 Hz NdYag laser. For collision-
induced dissociation, the collision cell was floated at 1 kV, the
resolution of the precursor ion selection was set to 150 FWHM,
and air was used as the collision gas at 5610
27 Torr.
Analysis of peptide hydrolysis data
In the presence of H2
18O, protease-peptide interactions can
result in the incorporation of up to two
18O-atoms in carboxylate
peptide products [19,20]. The second incorporation, which
depends on the ability of the enzyme to rebind the cleaved
peptide product and catalyze the carbonyl oxygen exchange
reaction, was rarely observed. Therefore, in the presence of 50%
H2
18O, peptides that were proteolytically generated displayed an
18O-isotope signature of 1:1 (unlabeled: single labeled) at their
newly-formed C-termini.
The extent of
18O incorporation for each peptide was
determined by linear regression analysis of the raw spectra using
least squares fitting with a model consisting of a linear
combination of four components, the theoretical average in
isotope clusters positioned at m/z, (m+2)/z and (m+4)/z, and a
constant term. Linear regression computed four multipliers, the
amplitude of the unlabeled, singly-labeled, and doubly-labeled
peaks, and the baseline. It was thereby possible to measure the
unlabeled, singly labeled, and doubly labeled contributions for
each peptide identified in the mass spectrum.
We used the following criteria to positively identify new
cleavage products: a) a new C-terminus had to be formed to
allow
18O-incorporation; b) the single
18O-incorporation had to
account for 50% of the entire isotopic envelope (610%
experimental error); c) peptide needed to be observed in replicate
analyses and in consecutive time points (except for the overnight
time point); and d) labeled peptide should not be detected at the
zero time point, with the following exceptions: e) peptides that
started off with .60% unlabeled fraction, with subsequent
decrease in unlabeled peptide were included; f) peptides with
initial single label, followed by double label were included; g)
peptides with single label in a minority of time points slightly
.60% were included; h) if the single label significantly increased
with time, peptides with slight labeling at 0 min were included;
and i) As expected, proteolytic products that were formed while
the C-termini stayed intact did not incorporate
18O. Hence, these
newly generated peptides with intact C-termini: 1) should display
Falcipain Hemoglobin Cleavage
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peptides should be seen in at least two time points and in replicate
analyses (unless it is observed only in the overnight time point); and
3) these unlabeled peptides should not be seen at not at the zero
time point.
Hydrolysis of Human Hemoglobin
For analysis of hydrolysis of intact hemoglobin, reaction
conditions and enzyme concentration were as described for
experiments with 12-mer peptides, except that the substrate was
2.5 mM human hemoglobin (Sigma) and were incubated for
180 minutes or overnight. At the end of the incubation, peptides
were separated by ultra-filtration (12,0006g for 40 min; Sartorius
Vivaspin columns, nominal molecular weight limit 3,000 or 5,000
Daltons). Ultra-filtrates containing the cleavage products were
analyzed by LC MS/MS on a QStar XL mass spectrometer
(Applied Biosystems/Sciex) equipped with a nano 2DLC system
(Eksigent) and a Nanospray II source (Applied Biosystems/Sciex).
External calibration was performed in MS/MS mode using
fragment ions of Glu-fibrinopeptide as references. An LC Packings
PepMap C18 trap column (300 mm i.d., 5 mm length, 300 A ˚ pore
size, 5 mm particle size) and a column (75 mm i.d., 15 cm length)
self-packed with Jupiter Proteo C12 end-capped material (90 A ˚
pore size, 4 mm particle size) were used for desalting and reversed
phase peptide separation, respectively. A 20 minute linear
gradient from 2% B to 50% B was run at a 250 nL/min flow
rate, utilizing solvents A: (2% acetonitrile/0.1% formic acid) and B
(80% acetonitrile/0.08% formic acid). Precursor ion selection
employed an automated routine that consisted of a one survey MS
scan (1 s, m/z 400–1700) and two MS/MS scans (1 s, m/z 60–
1500); nitrogen served as a collision gas and collision energy was
automatically adjusted depending on the size and charge state of
the precursor ion. Mass spectrometry data were analyzed using a
laboratory information system that utilized Mascot Distiller
software (Matrix Science) for spectral processing and peak
detection. Peptides were identified by using the Mascot algorithm
(Matrix Science; version 2.1) to search against human proteins in
the SwissProt database via nonspecific digestion (i.e. ‘‘no enzyme’’
search). Identities of peptides were confirmed by manual
interpretation of the MS/MS data.
Results
Expression of falcipain-2 and falcipain-3
Falcipain-2 and falcipain-3 were expressed in bacteria, purified,
and refolded to active proteases. These proteases have previously
been shown to readily hydrolyze hemoglobin [15,17], and also to
cleave peptide substrates after Leu-Arg-, Val-Leu-Arg-, and Val-
Leu-Lys- [17]. These substrates were tested based on the known
specificities of other papain family cysteine proteases [21].
However, more detailed characterization of the substrate specific-
ity of these proteases has not been reported. To better characterize
falcipain activities and determine whether a clear pathway of
hemoglobin degradation by falcipains is present, activities were
studied by three assays, evaluating action against a tetrapeptide
library, 12-mer peptides representing the sequences of a and b
globin, and intact hemoglobin. All assays were performed under
conditions matching, to the best of our knowledge, those of the P.
falciparum food vacuole, the site of hemoglobin hydrolysis by the
falcipains, notably at pH 5.5.
Hydrolysis of a positional scanning tetrapeptide library
To study the amino acid preferences of falcipain-2 and
falcipain-3 at the P1 to P4 positions, we studied hydrolysis of
positional scanning tetrapeptide libraries (Fig. 1). In each library,
each tetrapeptide had a fixed amino acid at one position (P1,P 2,
P3,o rP 4) and randomized amino acids at the other positions [18].
P1 preferences for the two enzymes were similar. Both falcipain-2
and falcipain-3 showed a P1 preference for Arg, with activity also
high against substrates with P1 Lys, Gln, Thr, and Met.
Considering the P2 position, both falcipain-2 and falcipain-3 had
a strong preference for Leu and a slight preference for Val. Amino
acid preferences were less pronounced at the P3 and P4 positions,
although specificities for the two enzymes were similar. At P3,
positively charged amino acids, hydrophobic amino acids, and Pro
were preferred. P4 His and Asn were preferred by both enzymes,
with particularly low activity against peptides with hydrophobic
amino acids at P4.
Hydrolysis of globin peptides
We next evaluated cleavage of 12-mer peptides spanning the
sequences of a and b globin, with 4 amino acid overlaps such that
each potential cleavage site was considered with at least 3 P or P9
amino acids present. To best distinguish falcipain cleavage
products from minor fragments contaminating synthetic peptides,
the proteases and peptide substrates were incubated with 50%
H2
18O. With proteolytic cleavage, the C-terminal ends of the
newly generated peptides, but not false products, bore
18O either
by enzyme catalysis or isotope exchange [19,20]. Peptides were
incubated with falcipain-2 or falcipain-3 for varied intervals, and
reaction products were assessed by MALDI-TOF MS/MS
analysis. We used stringent criteria to distinguish newly generated
peptides from false positive and ambiguous products, based on
ratios of labeled to unlabeled peptides and frequencies of
appearance at several time points. Multiple cleavage sites were
identified for both falcipains (Fig. 2a–d, top arrows). Considering
the sequences most preferred in our positional scanning library
analysis, cleavages by falcipain-2 were seen at 25 of 36 positions
with P2 Leu and by falcipain-3 at 22 of 36 such positions. Analysis
of the step-wise hydrolysis of peptides over time yielded a complex
picture for both a and b globin and either falcipain-2 or falcipain-3
(Fig. 3). Identification of the most common amino acids at
cleavage sites was, of course, influenced by the prevalence of
different residues in hemoglobin. At the P2 position, Leu was most
common, but cleavages of peptides with P2 Val and other amino
acids were also well represented (Fig. 4). A more thorough analysis
of cleavage for each amino acid at each P1–4 position is in
supplementary material (Table S1; Figure S1). These experiments
also showed that the most preferred P19 amino acids were Ala and
Leu. However, this preference was modest, with cleavages
demonstrated at sites with multiple different prime-side amino
acids. At the P29 position Ala was slightly preferred. There was no
particular amino acid preference at the P39 or P49 position.
Hydrolysis of intact human hemoglobin
For our third analysis, we assessed hydrolysis of full-length
hemoglobin by falcipain-2 and falcipain-3. A simple step-wise
pathway for hemoglobin degradation was not seen. Rather, we
identified over a hundred peptides of molecular weight 9 kDa or
less after 5 minute incubations of human hemoglobin with
falcipain-2 or falcipain-3 (data not shown). For simplicity, we
therefore concentrated on identification of hemoglobin cleavage
fragments after an extended incubation with falcipain-2 or
falcipain-3. Reactions were performed after incubation of
hemoglobin with 50% H2
18O, and the identities of hemoglobin
cleavage fragments were characterized by LC-MS/MS. Data were
filtered based on
18O incorporation, as described above for
analysis of peptide hydrolysis. We then mapped cleavage sites on
Falcipain Hemoglobin Cleavage
PLoS ONE | www.plosone.org 3 April 2009 | Volume 4 | Issue 4 | e5156Figure 1. Cleavage preferences of falcipain-2 and falcipain-3 against a tetrapeptide library. P1 P2,P 3 and P4 complete diverse libraries
were used to determine specificities. Activities are displayed as percentage of the maximum for each position. Amino acids are represented by the
single-letter code (n is for norleucine). Error bars represent standard deviations of results from three experiments.
doi:10.1371/journal.pone.0005156.g001
Falcipain Hemoglobin Cleavage
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Cleavage sites were identified in both the loops (blue color) and
helices (red color) of human globin, with no particular preference
for buried or exposed cleavage sites on the hemoglobin tertiary
structure (Fig. 2e). Of note, the data obtained for falcipain-2 were
nearly identical to those for falcipain-3 for hydrolysis of
hemoglobin and were very similar to those for hydrolysis of globin
peptides by both proteases.
Discussion
Falcipain-2 and falcipain-3 are critical hemoglobinases of P.
falciparum. These enzymes have been extensively studied, with
characterization of kinetic properties [15,17], confirmation of key
functions with inhibitor [22,23] and gene disruption studies
[10,11], and identification of unique motifs that are required for
protein folding [24,25], interaction with hemoglobin [26], enzyme
structure [27,28,29], and targeting to the parasite food vacuole
[30,31]. However, characterization of a specific pathway for
hemoglobin hydrolysis by falcipain-2 and falcipain-3 has been
difficult. We now present a detailed analysis of hydrolysis of short
peptide substrates, 12-mer peptides encompassing a and b globin,
and intact human hemoglobin by falcipain-2 and falcipain-3. We
show that the proteases have distinct specificity for short peptide
substrates with Leu at the P2 position, but that against larger
substrates specificity is less marked. Indeed, the proteases rapidly
cleaved globin peptides and intact hemoglobin at multiple
different sequences. These results suggest that falcipain-2 and
falcipain-3 do not cleave host hemoglobin via an ordered process,
but rather that the proteases efficiently cleave the substrate by
rapid hydrolysis at many different sites on the protein.
We evaluated hydrolysis of small peptide combinatorial libraries
by falcipains, a standard technique. Other proteases that have
been evaluated in this manner include caspases [32], the serine
Figure 2. Hemoglobin cleavage sites for falcipain-2 and falcipain-3. A–D. Globin peptides and intact human hemoglobin. Cleavage
sites for the two proteases based on analysis as described in Methods of hydrolysis of 12-mer peptides (top arrows, data from all time points) and
intact hemoglobin (lower arrows, data from both 180 min and overnight time points) are shown for a and b globin. E. Intact human hemoglobin.
The schematic shows a globin subunits in white and b globin subunits in yellow. P1 residues at cleavage sites within helices are in red and within
loops are in blue.
doi:10.1371/journal.pone.0005156.g002
Falcipain Hemoglobin Cleavage
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[35], a tick asparaginyl endopeptidase [36], and human kalikreins
[37]. Although this methodology is most useful for highly selective
enzymes, valuable information can also be extracted from
substrate profiles with enzymes that are quite promiscuous, as in
the case of the falcipains and other papain family cysteine
proteases [21]. Of note, we observed marked selectivity in P2
preference for falcipains using small peptide substrates. Hydro-
phobic amino acids at P2 were strongly preferered by falcipain-2
and falcipain-3, as seen with many other papain-family proteases
[21]. However, the specific preference for a single amino acid,
Leu, at P2, was more striking than the case for any of the 8 other
papain-family proteases recently studied in the same manner [18].
Of the 8 other proteases, the next most specific enzyme was
papain, with about 5-fold greater activity for peptides with Val at
P2 than any other peptides. Other papain-family proteases not
included in the prior survey appear to show a stronger preference
for P2 Leu, notably the human proteases cathepsin K and
cathepsin S [21]. As discussed in more detail below, we found that
the striking preference for P2 Leu in small substrates did not
predict specificity only for cleavage sites with P2 Leu in larger
peptide or protein substrates. Nonetheless, this specificity has been
seen also in small molecule inhibitors of falcipain-2 and falcipain-
3; inhibitors with either Phe or Leu at P2 were effective, but
typically activity improved ,10-fold for fluoromethyl ketones,
vinyl sulfones, and aldehydes with P2 Leu [23,38,39]. Thus,
Figure 3. Time course for cleavage of globin peptides. Schematic representation of cleavage fragments over the indicated time points based
on analysis of cleavage of 12-mer peptides spanning the sequences of a and b globin.
doi:10.1371/journal.pone.0005156.g003
Falcipain Hemoglobin Cleavage
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protein substrates, the elaboration of enzyme specificity using
tetrapeptide scanning libraries provided accurate prediction of
optimal small molecule inhibitors. Appreciation of the fine
specificity of inhibition of falcipains is contributing to drug
discovery efforts directed against these proteases [6].
Our experimental conditions for globin peptides and native
hemoglobin were slightly modified from a previous study [14], so
that they were suited for
18O incorporation and subsequent mass
spectrometry. These conditions were designed to match those in
the intact food vacuole, including modest reducing conditions
(1 mM DTT) and pH of 5.5. Prior studies have estimated the pH
of the food vacuole at 4.5–5.8 [40,41,42,43] and shown the pH
optima of falcipain-2 and falcipain-3 to be ,4.5–6.0 [15,17]. The
enzyme:substrate ratio was slightly higher than that used
previously [14]; these conditions gave us optimum results with
substrate degradation and
18O incorporation, which is also an
enzyme-dependent process.
Ordered pathways for the hydrolysis of hemoglobin have been
demonstrated in studies with isolated aspartic proteases from two
parasites that hydrolyze this substrate, schistosome worms that
degrade hemoglobin extracellularly [44] and malaria parasites that
degrade hemoglobin in an intracellular acidic organelle [12].
However, prior attempts to map out pathways of hemoglobin
hydrolysis for cysteine proteases of schistosomes or malaria
parasites have been unsuccessful due to an inability to identify
the ordered generation of cleavage fragments (Shenai BR, Sajid
M, and Rosenthal PJ, unpublished observations). A key goal of the
present study was to more rigorously test the hypothesis that
falcipain-2 and falcipain-3 indeed hydrolyze hemoglobin through
an ordered pathway of cleavage events and, in any event, to
identify globin peptide and hemoglobin cleavage fragments after
incubation with falcipains. Despite rigorous filtering to identify
only bona fide cleavage fragments, we found that falcipain-2 and
falcipain-3 cleaved hemoglobin simultaneously (within our limits of
analysis) at many sites. Thus, the enzymes appear to degrade
hemoglobin not via an ordered hydrolytic pathway, but through
rapid hydrolysis of multiple sites. This result is consistent with
known features of other papain-family cysteine proteases, which
also have quite broad specificity against protein substrates [21].
Indeed, the prototype enzyme papain is used in a number of
industrial applications that take advantage of its broad substrate
specificity. Lysosomal cysteine proteases similarly demonstrate
broad specificity, and appear to be responsible for extensive
proteolytic activity in this organelle [21]. In malaria parasites,
where the food vacuole appears to serve as the homolog of the
lysosome, and where hemoglobin appears to be the primary
proteolytic substrate [12], it seems likely that falcipain-2 and
falcipain-3 are responsible for the bulk of cleavages that reduce
hemoglobin from a complex tetramer to single amino acids.
Additional proteases, notably plasmepsin I–IV [12,45], dipeptidyl
aminopeptidase I [46,47] and falcilysin [48,49], also appear to
contribute to the efficient hydrolysis of hemoglobin in the food
vacuole, and the presence of multiple proteases of multiple classes
suggests a degree of redundancy in this process [9]. Despite the
presence of multiple proteases in the food vacuole, it is noteworthy
that treatment of cultured parasites with specific inhibitors of
cysteine proteases fully blocked the hydrolysis of hemoglobin,
highlighting the key role for the falcipains in this process [22].
Knockout of plasmepsins I–IV, the 4 known food vacuole
plasmepsins, was not lethal to P. falciparum (although parasites
with knockout of all four food vacuole plasmepsins demonstrated
abnormal development) [50,51]. In contrast, knockout of either
falcipain-3 [11] or dipeptidyl aminopeptidase I [46] appears to be
lethal, arguing for essential functions for these enzymes, although
it is not known if the essential functions are hydrolysis of
hemoglobin. Of note, it has recently also been shown that the
activation of food vacuole plasmepsins is primarily mediated by
falcipains, offering further evidence of a primary role for falcipains
in mediating the hydrolysis of hemoglobin by erythrocytic P.
falciparum parasites [52].
Results showing potent hydrolysis of hemoglobin by both
falcipain-2 and falcipain-3 [14 and this report] and the localization
of these falcipains in the food vacuole [7,30] argue that a key
function of these proteases is hemoglobin hydrolysis. However, it
remains possible that they also perform other key functions,
including the processing of plasmepsins (as discussed above) and
possibly other food vacuole proteases [52] and the hydrolysis of
erythrocyte cytoskeletal proteins to facilitate erythrocyte rupture
[53,54,55]. As falcipain-2 and falcipain-3 are not biochemically
identical and as they are expressed sequentially during the parasite
life cycle, they may have non-overlapping biological roles,
explaining in part the redundancy of papain-family proteases in
P. falciparum.
Of interest, falcipain-2 and falcipain-3 contain a short C-
terminal insertion that is unique among studied papain-family
proteases and mediates interaction between the proteases and
hemoglobin independent of the enzyme active site [29]. Removal
of the insertion from falcipain-2 rendered a protease that remained
active against peptide substrates, but could not hydrolyze
hemoglobin [26]. This feature of the falcipains likely facilitates
particularly efficient hydrolysis of hemoglobin and may contribute
to the ability of the proteases to cleave hemoglobin at multiple
sites. However, it is difficult to predict interaction between the
protease and substrate based on known structures [28,29], as once
initial cleavages of hemoglobin take place, the structure of
hemoglobin will be altered, and multiple peptide bonds will
presumably be accessible to cleavage by the falcipains.
A prior study identified hemoglobin cleavage fragments after
incubation of this protein with crude P. falciparum food vacuole
extracts [56]. This analysis identified a series of hemoglobin
cleavage fragments, with cleavage sites at mean intervals of 8.4
amino acids. Comparison of identified cleavage sites from the
prior analysis of food vacuole extracts with our analysis of cleavage
by recombinant falcipains identified many shared cleavage sites,
but also cleavages identified only after incubation with food
vacuole extract or only after incubation with recombinant
falcipains. Specifically, only 15 of 37 cleavages identified in the
prior study after incubation with food vacuole extracts were seen
after incubation with falcipain-2 or falcipain-3. Therefore, some
hemoglobin cleavages appeared to be generated uniquely by
proteases other than the falcipains. However, considering both our
globin peptides and intact hemoglobin results, we observed over
100 different cleavage sites within hemoglobin, with 90 of these
not seen after incubation with food vacuole extract. Some falcipain
activity may have been missed in studies of vacuole extracts due to
chosen assay conditions, the presence of enzyme inhibitors in
extracts, or loss of enzymes during sample preparation. In any
Figure 4. Cleavage site preferences for falcipain-2 and falcipain-3. Preferences for amino acids (single letter code) at P1-P4 and P19-P49 are
shown schematically. At each position, the height of each amino acid corresponds to its frequency at cleavage sites based on analysis of a and b
globin. WebLogo (weblogo.berkeley.edu), a free software for plotting consensus sequences, was used to plot P4- P49 preferences.
doi:10.1371/journal.pone.0005156.g004
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proteases is likely required for optimal hydrolysis of hemoglobin,
the sequential expression of falcipain-2 in early trophozoites and
then falcipain-3 in late trophozoites and schizonts [7] provides
potent hemoglobinolytic activity for erythrocytic P. falciparum
parasites.
Our study has important limitations. First, the precise analysis
of cleavage of globin peptides or hemoglobin by falcipains proved
to be technically very challenging. Analysis of products after
incubations of globin peptides with the proteases identified many
products, suggesting the presence of contaminating fragments in
commercial peptides. We therefore used
18O labeling and
assessments for reproducibility over time to identify genuine
cleavage fragments. However, this approach necessarily involved
the establishment of arbitrary filtering criteria, and may have
inappropriately excluded some cleavage sites and/or included false
cleavage sites. Second, analysis of cleavage of intact hemoglobin
was cost- and labor-intensive, limiting our ability to evaluate a
broad range of hydrolytic time points. Thus, our ability to identify
any single hemoglobin cleavage site for falcipain-2 or falcipain-3
from our studies is somewhat limited, although cleavages seen
consistently with both falcipains at multiple time points and with
both peptide and intact hemoglobin substrates are very likely to
represent true biological cleavage sites. Third, our study used
ultrafiltration to isolate peptide cleavage fragments generated from
intact hemoglobin. This procedure might lead to selective loss of
certain peptides. To investigate that possibility, we previously
analyzed tryptic digests of proteins prior to and after ultrafiltration,
and we did not observe significant differences between the samples
(Hardt, M., unpublished observation). Nonetheless, we cannot
exclude the possibility that certain peptides might have been lost
due to this separation technology, but, based on our overall
sequence coverage of hemoglobin, this potential loss appeared to
be minimal. In any event, our overall result is clear: falcipain-2
and falcipain-3 are capable of rapid hydrolysis of hemoglobin at
multiple cleavage sites.
It is of interest that two common polymorphisms leading to
alterations in the sequence of hemoglobin, HbS and HbC, offer
protection against severe malaria [57,58,59,60,61], and many
other polymorphisms in hemoglobin may offer protection against
malaria. It is possible that this protection is mediated, in part, by
altered susceptibility of mutant hemoglobins to hydrolysis by
parasite proteases, including falcipains. This will be an interesting
area for future study.
In summary, we have characterized the proteolytic specificity of
two key cysteine protease hemoglobinases of the malaria parasite
P. falciparum. Both falcipain-2 and falcipain-3, which are expressed
sequentially, contribute importantly to the necessary hydrolysis of
hemoglobin by intraerythrocytic parasites. Indeed, our results
show that the falcipains rapidly hydrolyze hemoglobin at multiple
sites, allowing efficient degradation of this substrate, and
suggesting that the falcipains are the key proteases responsible
for the massive hydrolysis of hemoglobin that occurs over the
course of the intraerythrocytic life cycle of P. falciparum.
Supporting Information
Figure S1 Graphical representation of amino acid preferences at
P1–P4. P1–P4 amino acid preferences were plotted as a
percentage of total cleavages, alongside percentage occurrence of
each amino acid in the primary sequences of a and b globin.
Found at: doi:10.1371/journal.pone.0005156.s001 (0.51 MB TIF)
Table S1 This table shows (in two separate worksheets)
sequences of the precursor peptide (for 12mer a and b globin
peptides) and peptide products obtained as a result of falcipain
mediated proteolysis.
Found at: doi:10.1371/journal.pone.0005156.s002 (0.05 MB
XLS)
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